A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00467649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Randomized, Open Label, Parallel Group, Multicenter Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
Study identification
- NCT ID
- NCT00467649
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Interventions
- basal insulin (Lantus® [insulin glargine], or Levemir® [insulin detemir]) Drug
- pramlintide acetate (Symlin) Drug
- rapid acting insulin (Humalog® [insulin lispro], Novolog® [insulin aspart], or Apidra® [insulin glulisine]) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2007
- Primary completion
- Mar 31, 2008
- Completion
- Mar 31, 2008
- Last update posted
- Apr 13, 2015
2007 – 2008
United States locations
- U.S. sites
- 37
- U.S. states
- 27
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Northport | Alabama | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Loma Linda | California | — | — |
| Research Site | Aurora | Colorado | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Maitland | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | North Miami Beach | Florida | — | — |
| Research Site | Plantation | Florida | — | — |
| Research Site | Roswell | Georgia | — | — |
| Research Site | Peoria | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Lexington | Kentucky | — | — |
| Research Site | Baton Rouge | Louisiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Grand Rapids | Michigan | — | — |
| Research Site | Jackson | Mississippi | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Butte | Montana | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Hamilton | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | Staten Island | New York | — | — |
| Research Site | Mentor | Ohio | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Bridgeville | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Aiken | South Carolina | — | — |
| Research Site | Bartlett | Tennessee | — | — |
| Research Site | Nashville | Tennessee | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Olympia | Washington | — | — |
| Research Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00467649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2015 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00467649 live on ClinicalTrials.gov.